TOKYO, Japan: Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group
Stockholm, Sweden, November 8, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today updated their revenue outlook for
Mon, Nov 04, 2024 16:41 CET Report this content Medivir has entered into a clinical trial collaboration and
Stockholm, Sweden November 1, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed
Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.
Copyright© 2025 Creative Bharat Powered By A Buzz Company